RXO (NYSE:RXO) Given New $21.00 Price Target at TD Cowen

RXO (NYSE:RXOGet Free Report) had its target price boosted by TD Cowen from $14.00 to $21.00 in a note issued to investors on Friday. The firm currently has a “hold” rating on the stock. TD Cowen’s price target would suggest a potential downside of 8.61% from the stock’s current price.

Other analysts have also issued research reports about the company. Bank of America lowered their price target on RXO from $17.00 to $15.00 and set a “neutral” rating for the company in a report on Wednesday, March 25th. Susquehanna boosted their price target on RXO from $12.00 to $14.00 and gave the company a “negative” rating in a report on Wednesday, April 22nd. Barclays reiterated an “overweight” rating and issued a $20.00 price target on shares of RXO in a report on Friday. Citigroup boosted their price target on RXO from $15.00 to $18.00 and gave the company a “neutral” rating in a report on Monday, February 9th. Finally, UBS Group reissued a “neutral” rating on shares of RXO in a research note on Sunday, February 8th. Two investment analysts have rated the stock with a Buy rating, ten have given a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, RXO presently has an average rating of “Reduce” and a consensus price target of $17.85.

Check Out Our Latest Analysis on RXO

RXO Stock Down 0.6%

Shares of NYSE RXO opened at $22.98 on Friday. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.27 and a current ratio of 1.27. The firm has a market capitalization of $3.78 billion, a price-to-earnings ratio of -39.63, a PEG ratio of 35.08 and a beta of 1.96. The stock has a 50 day moving average price of $15.96 and a 200 day moving average price of $15.01. RXO has a 52-week low of $10.43 and a 52-week high of $23.37.

RXO (NYSE:RXOGet Free Report) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.09) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.09). The firm had revenue of $1.43 billion during the quarter, compared to analyst estimates of $1.34 billion. RXO had a negative return on equity of 0.44% and a negative net margin of 1.74%.RXO’s quarterly revenue was down .6% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.03) earnings per share. Sell-side analysts expect that RXO will post 0.02 earnings per share for the current year.

Hedge Funds Weigh In On RXO

A number of large investors have recently bought and sold shares of the business. Cassaday & Co Wealth Management LLC bought a new position in RXO in the first quarter worth approximately $29,000. Dimensional Fund Advisors LP raised its stake in RXO by 32.7% in the first quarter. Dimensional Fund Advisors LP now owns 2,048,903 shares of the company’s stock worth $29,949,000 after buying an additional 504,955 shares in the last quarter. Illinois Municipal Retirement Fund bought a new position in RXO in the first quarter worth approximately $1,537,000. Emerald Mutual Fund Advisers Trust bought a new position in RXO in the first quarter worth approximately $4,034,000. Finally, Emerald Advisers LLC raised its stake in RXO by 434,029.7% in the first quarter. Emerald Advisers LLC now owns 438,471 shares of the company’s stock worth $6,410,000 after buying an additional 438,370 shares in the last quarter. Institutional investors own 92.73% of the company’s stock.

More RXO News

Here are the key news stories impacting RXO this week:

  • Positive Sentiment: Company issued upbeat Q2 outlook — RXO expects $27M–$37M in adjusted EBITDA and said contract rates are trending to high-single-digit gains, a clear near-term profitability signal for investors. RXO expects $27M-$37M Q2 adjusted EBITDA
  • Positive Sentiment: Q1 revenue topped Street estimates ($1.43B vs. ~$1.34B expected) and management emphasized improving truckload volumes and a stronger brokerage sales pipeline — supporting the outlook and prompting investor relief. RXO Announces First-Quarter Results and Second-Quarter Outlook
  • Positive Sentiment: Media coverage highlights a tech turnaround and that earnings/guidance helped allay Amazon-related competitive concerns — narrative that can sustain multiple expansion as investors price in execution on the tech stack and brokerage growth. RXO’s tech turnaround: why investors are watching
  • Neutral Sentiment: Reported EPS of ($0.09) matched consensus, and some outlets characterize the quarter as a miss on profitability but a beat on revenue — a mixed print that leaves valuation sensitive to execution on guidance. RXO (RXO) Reports Q1 Loss, Tops Revenue Estimates
  • Negative Sentiment: CEO Drew Wilkerson warned “we’re still nowhere near normalized earnings,” underscoring that margin recovery is incomplete and that investors should expect more operating volatility before sustainable profits. We’re still nowhere near normalized earnings right now, says RXO CEO Drew Wilkerson
  • Negative Sentiment: GAAP metrics remain weak: EPS declined year-over-year (from -$0.03 to -$0.09) and net margin stayed negative, leaving the stock dependent on successful execution of the guidance and margin improvement. RXO misses first-quarter estimates but stock gains 3% on outlook

RXO Company Profile

(Get Free Report)

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.

Further Reading

Analyst Recommendations for RXO (NYSE:RXO)

Receive News & Ratings for RXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RXO and related companies with MarketBeat.com's FREE daily email newsletter.